This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goodison, S. Articles by Tarin, D. Search for Related Content PubMed PubMed Citation Articles by Goodison, S. Articles by Tarin, D.

(American Journal of Pathology. 1998;153:1221-1228.)
© 1998 American Society for Investigative Pathology

Regular Articles

Multiple Intron Retention Occurs in Tumor Cell CD44 mRNA Processing

Steven Goodison* , Kazuhiro Yoshida , Michael Churchman and David Tarin*

From the UCSD Cancer Center,* University of California, San Diego, La Jolla, California, and the Nuffield Department of Pathology and Bacteriology, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom

Markedly increased overall levels of CD44 transcripts and proteins have been recognized in many tumors and the inappropriate expression and abnormal assembly of the CD44 variable exons has been linked to both tumor growth and metastatic potential. We have also previously observed the aberrant inclusion of intron 9 in CD44 mRNA transcripts in tumor tissues. In this study we assessed whether such retention is specific to certain introns or is a more general phenomenon affecting CD44 gene expression in tumor cells. Intron 18 was cloned and sequenced from genomic DNA and the novel sequences analyzed and used to create intron 18-specific probes. The newly characterized intron was found to have consensus 5' splice site and branchpoint sequences but a suboptimal 3' splice site. The status of CD44 intron 18 retention or excision was assessed in a colon tumor cell line (HT29) and in tissue from 20 colorectal tumors and matched normal mucosa. The intron was shown to be retained in transcripts from 15 of the 20 (75%) carcinomas but in only 3 of the 20 (15%) matched normal samples. These results compare with 80% retention of CD44 intron 9 in colonic carcinoma tissue mRNA and confirm that multiple abnormalities of CD44 mRNA processing occur in tumor cells.

This article has been cited by other articles:

				H. Ner-Gaon and R. Fluhr Whole-Genome Microarray in Arabidopsis Facilitates Global Analysis of Retained Introns DNA Res, January 1, 2006; 13(3): 111 - 121. [Abstract] [Full Text] [PDF]

				I. P. Michael, L. Kurlender, N. Memari, G. M. Yousef, D. Du, L. Grass, C. Stephan, K. Jung, and E. P. Diamandis Intron Retention: A Common Splicing Event within the Human Kallikrein Gene Family Clin. Chem., March 1, 2005; 51(3): 506 - 515. [Abstract] [Full Text] [PDF]

				S. T. Forrest, K. G. Barringhaus, D. Perlegas, M.-L. Hammarskjold, and C. A. McNamara Intron Retention Generates a Novel Id3 Isoform That Inhibits Vascular Lesion Formation J. Biol. Chem., July 30, 2004; 279(31): 32897 - 32903. [Abstract] [Full Text] [PDF]

				V. Urquidi, D. Sloan, K. Kawai, D. Agarwal, A. C. Woodman, D. Tarin, and S. Goodison Contrasting Expression of Thrombospondin-1 and Osteopontin Correlates with Absence or Presence of Metastatic Phenotype in an Isogenic Model of Spontaneous Human Breast Cancer Metastasis Clin. Cancer Res., January 1, 2002; 8(1): 61 - 74. [Abstract] [Full Text] [PDF]

				K. Aogi, K. Kitahara, V. Urquidi, D. Tarin, and S. Goodison Comparison of Telomerase and CD44 Expression as Diagnostic Tumor Markers in Lesions of the Thyroid Clin. Cancer Res., October 1, 1999; 5(10): 2790 - 2797. [Abstract] [Full Text] [PDF]